We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Stored Blood for Transfusion Is Practical After Heart Surgery

By LabMedica International staff writers
Posted on 01 Nov 2015
Print article
Image: Blood transfusion bags containing different blood types (Photo courtesy of Terinah DoBa).
Image: Blood transfusion bags containing different blood types (Photo courtesy of Terinah DoBa).
Patients often need transfusions of red blood cells to replace the blood they have lost during major surgeries, however, the question of whether stored blood is safe for heart surgery patients has had mixed answers.

Red blood cells (RBCs) or erythrocytes that transport oxygen throughout the body go through several changes while in storage, potentially decreasing their oxygen-carrying ability and until now, it has not been clear as to whether such changes affect patient outcome after receiving transfusions.

Clinical scientists at the Karolinska University Hospital (Stockholm, Sweden) identified all patients who underwent coronary artery bypass graft surgery, heart valve surgery, or both between 1997 and 2012. Transfusion data were obtained from the nationwide register of blood transfusions database. Storage of RBCs was classified with discrete patient groups who had exclusively received blood stored less than 14 days, 14 to 27 days, or 28 to 42 days, and a mixed storage category for patients receiving blood of mixed age. Follow-up was completed on December 31, 2013.

Between 1997 and 2012, 47,071 patients were transfused in connection with cardiac surgery in nine Swedish hospitals. Women constituted 39.2% and the mean ±SD age was 70.0 ±9.7 years. Of these patients, 36.6% exclusively received RBCs stored less than 14 days; 26.8%, RBCs stored 14 to 27 days; 8.9%, RBCs stored 28 to 42 days; and 27.8%, RBCs of mixed age. Most clinical parameters were similar in the groups, although the less common blood groups such as AB and B, were more common with longer storage. Recipients of the freshest blood received more transfusions, 3.1 versus 2. No differences were observed for a range of comorbidities. After investigating patient outcomes, the team found that the use of stored blood units did not influence heart surgery patient outcomes.

Ulrik Sartipy, MD, PhD, the lead author of the study said, “This study is by far the largest investigation focusing on the issue of blood storage in this very sensitive patient group, and we find absolutely no hint of negative health effects associated with stored blood.” The study provides very firm reassurance that the current blood storage practices are safe. The study was published on October 20, 2015, in the Journal of the American Medical Association (JAMA).

Related Links:

Karolinska University Hospital


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.